Drug intelligence / Profile preview

cryopreserved platelets

Development stage
Phase 4
Lead developer
Cellphire Therapeutics
Modality
Tissue Cells → Other Cell Types → Cell Therapies
Administration
Intravenous
01

Overview

Cryopreserved platelets are human platelet concentrates that have been preserved by freezing—typically at −80°C using 5–6% dimethyl sulfoxide (DMSO) as a cryoprotectant and diluted in plasma. This process extends their shelf life from the standard 5–7 days for liquid-stored platelets to at least one year and potentially up to 12 years. After thawing, these preactivated platelets are used primarily for therapeutic transfusion in bleeding patients (not prophylactically), especially in settings where fresh platelet supply is limited or logistics are challenging (e.g., remote hospitals, military environments). Cryopreservation alters some platelet properties—reducing post-transfusion survival and aggregation—but maintains or enhances hemostatic function due to increased activation state and procoagulant activity. Clinical studies show that cryopreserved platelets are effective for controlling bleeding with safety profiles comparable to conventional products[1][2][3][9].

Other names
frozen plateletsCPP

Beyond the preview

Go deeper on cryopreserved platelets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cryopreserved platelets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call